What is BPC-157? A Comprehensive Research Guide

What is BPC-157?

BPC-157, or Body Protection Compound-157, is a synthetic pentadecapeptide consisting of 15 amino acids. It is derived from a protective protein found naturally in human gastric juice. First described in the research literature in the early 1990s, BPC-157 has become one of the most extensively studied cytoprotective peptides, with over 100 published research studies examining its properties in laboratory and animal models.

The peptide’s amino acid sequence is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. It does not occur naturally in this isolated form but is a stable fragment of the larger body protection compound found in gastric secretions. All BPC-157 available for research is synthetically manufactured via solid-phase peptide synthesis (SPPS).

Key Takeaways

• BPC-157 is a synthetic 15-amino acid peptide derived from human gastric juice proteins
• Over 100 research studies published on its cytoprotective properties
• Studied primarily in cell culture and animal models
• Stable in acidic environments (unlike many peptides)
• Available as lyophilized powder for research use only

Research History

BPC-157 research originated from the discovery that gastric juice contains proteins with tissue-protective properties. Researchers at the University of Zagreb, led by Dr. Predrag Sikiric, identified and characterized BPC-157 as a stable pentadecapeptide fragment with notable stability in acidic conditions — a property unusual among peptides, most of which degrade rapidly in low-pH environments.

Since its initial characterization, BPC-157 has been the subject of extensive preclinical research. The majority of studies have been conducted in rodent models and cell cultures, examining the peptide’s effects on various tissue types and biological pathways.

Studied Mechanisms

Research has identified several potential mechanisms through which BPC-157 may exert its cytoprotective effects in laboratory settings:

Nitric Oxide (NO) Pathway

Multiple studies have investigated BPC-157’s interaction with the nitric oxide system. Research in animal models suggests the peptide may modulate NO synthase activity, which plays roles in blood vessel dilation, inflammation signaling, and tissue repair processes.

Growth Factor Modulation

In vitro and animal studies have examined BPC-157’s effects on growth factor expression, including VEGF (vascular endothelial growth factor) and EGF (epidermal growth factor). These growth factors are key mediators in angiogenesis and tissue regeneration pathways.

FAK-Paxillin Pathway

Research has explored BPC-157’s interaction with the FAK-paxillin signaling pathway, which is involved in cell adhesion, migration, and survival — processes fundamental to tissue repair.

Areas of Research

BPC-157 has been studied across multiple research domains, primarily in animal models:

• Gastrointestinal research — Studies on gastric and intestinal mucosal protection in rodent models
• Musculoskeletal research — Studies examining tendon, ligament, and muscle tissue in injury models
• Vascular research — Studies on blood vessel formation and endothelial function
• Neurological research — Preliminary studies on neuroprotective properties in brain injury models

It is important to note that while preclinical research has been extensive, BPC-157 has not been approved for any therapeutic use and is sold exclusively for research purposes.

Stability and Form

One of BPC-157’s notable properties is its stability in acidic environments. Most peptides degrade rapidly at low pH, but BPC-157 maintains structural integrity in conditions similar to gastric acid. This unusual stability is attributed to its amino acid sequence and has made it a subject of interest in peptide chemistry research.

For research use, BPC-157 is supplied as a lyophilized (freeze-dried) powder. This form preserves the peptide’s integrity during shipping and storage. Before use, it is reconstituted with bacteriostatic water or other appropriate solvents.

BPC-157 and TB-500

BPC-157 is frequently studied alongside TB-500 (Thymosin Beta-4 fragment), another widely researched cytoprotective peptide. While BPC-157 research focuses on its gastric-origin protective properties, TB-500 research centers on its role in cell migration and actin regulation. Some researchers study both peptides together to examine potential complementary mechanisms.

13 Peptides offers BPC-157 as a single 10mg vial, a BPC-157/TB-500 20mg blend, and as part of the Glow Blend and Klow Blend.

Quality and Sourcing

Research-grade BPC-157 should meet specific quality standards. When sourcing BPC-157 for research, key indicators include:

• Certificate of Analysis (COA) — documenting purity and identity
• HPLC purity — typically 98%+ for research-grade material
• Mass spectrometry — confirming the correct molecular weight (1419.53 Da)
• Lyophilized form — for maximum stability during shipping

All BPC-157 products from 13 Peptides include a Certificate of Analysis. For more information about research peptide quality standards, see our guide: What Are Research Peptides?

BPC-157 is sold for research and laboratory use only. Not for human consumption. 13 Peptides does not make health claims or provide dosing instructions. For more information, see our FAQ and Glossary.